Background: Dyshidrotic eczema of the palms and soles is a common condition, which can be rather resistant to treatment. Therapy studies and their comparability are of clinical importance. Objective: As standardized assessment methods for the severity of this particular form of eczema are lacking, we developed a severity index for dyshidrotic eczema. Methods: The Dyshidrotic Eczema Area and Severity Index (DASI) is based on the severity grade of single items – number of vesicles per square centimetre (V), erythema (E), desquamation (S) and itch (I) – and the extension of the affected area (A) and is calculated with defined score points (p) as: DASI = (pv + pE = pS + pI) × pA. Results: In two treatment studies on dyshidrotic hand eczema, the DASI was found to be a simple and useful tool to assess the severity of dyshidrotic eczema and the effect of therapy. Conclusion: The DASI needs to be further validated in larger cohorts.

Keywords:
Severity index, Dyshidrotic eczema, Pompholyx, Treatment study
1.
Burton JL: Pompholyx; in Champion RH, Burton JL, Ebling FJG (eds): Textbook of Dermatology, ed 5. Oxford, Blackwell Scientific Publications, 1992, pp 559–562.
2.
Przybilla B, Ring J, Ruzicka T: Clinical aspects of atopic eczema: Synopsis; in Ruzicka T, Ring J, Przybilla B (eds): Handbook of Atopic Eczema. Berlin, Springer, 1991, pp 132–138.
3.
Lodi A, Betti R, Chiarelli G, Urbani CE, Crosti C: Epidemiological, clinical and allergological observations on pompholyx. Contact Dermatitis 1992;26:17–21.
4.
White JW: Dyshidrosis; in Marks G (ed): Principles and Practice of Dermatology. New York, Churchill-Livingstone, 1990, pp 411–412.
5.
Kerscher M, Plewig G, Lehmann P: PUVA bath therapy of recalcitrant dermatoses of the palms and the plants. Z Hautkr 1994;69:110–112.
6.
Schempp CM, Czech W, Schöpf E, Simon JC: Treatment of dyshidrotic palmoplantar eczema with tapwater iontophoresis. Akt Dermatol 1996; 22:198–201.
7.
Schempp CM, Müller H, Czech W, Schöpf E, Simon JC: Treatment of chronic palmoplantar eczema with local bath-PUVA therapy. J Am Acad Dermatol 1997;36:733–737.
8.
Wollina U, Uhlemann C, Elstermann D, Köber L, Barta U: Tapwater iontophoresis for hyperhidrosis – Positive effects on clearing time and relapse-free intervals in palmoplantar eczema (dermatitis). Hautarzt 1998;49:109–113.
9.
Grattan CEH, Carmichael AJ, Shuttleworth GJ, Foulds IS: Comparison of topical PUVA with UVA for chronic vesicular hand eczema. Acta Derm Venereol (Stockh) 1991;71:118–122.
10.
Odia SG, Vocks E, Rakoski J, Ring J: Successful treatment of dyshidrotic hand eczema using tap water iontophoresis with pulsed direct current. Acta Derm Venereol (Stockh) 1996; 76:472–474.
11.
Schmidt T, Abeck D, Boeck K, Mempel M, Ring J: UVA1 irradiation is effective in treatment of chronic vesicular dyshidrotic hand eczema. Acta Derm Venereol (Stockh) 1998; 78:318–319.
12.
European Task Force on Atopic Dermatitis: Severity scoring of atopic dermatitis: The SCORAD index. Dermatology 1993;186:23–31.
13.
Schäfer T, Dockerey D, Krämer U, Behrendt H, Ring J: Experiences with the severity scoring of atopic dermatitis in a population of German school children. Br J Dermatol 1997;137:558– 562.
14.
Costa C, Rilliet A, Nicolet M, Saurat JH: Scoring atopic dermatitis: The simpler the better? Acta Derm Venereol (Stockh) 1989;69:41–45.
15.
Bahmer FA, Schubert HJ: Quantification of the extent and the severity of atopic dermatitis: The ADASI score. Arch Dermatol 1991;127:1239.
16.
Przybilla B, Ring J, Kejzlar-Lisy G: Treatment of atopic eczema with UVAPUR – Clinical and immunological results. Akt Dermatol 1988;14: 326–329.
17.
Rajka G, Langeland T: Grading of the severity of atopic dermatitis. Acta Derm Venereol (Stockh) 1989;suppl 144:13–14.
18.
Wahlgren CF, Scheynius A, Hägermark Ö: Antipruritic effect of oral cyclosporin A in atopic dermatitis. Acta Derm Venereol (Stockh) 1990;70:323–329.
19.
Fredriksson T, Pettersson U: Severe psoriasis – Oral therapy with a new retinoid. Dermatologica 1978;157:238–244.
20.
Jemec GBE, Wulf HC: The applicability of clinical scoring systems: SCORAD and PASI in psoriasis and atopic dermatitis. Acta Derm Venereol (Stockh) 1997;77:392–393.
21.
Kutzner H, Wurzel H, Wolff HH: Are acrosyringia involved in the pathogenesis of dyshidrosis? Am J Dermatopathol 1986;8:109–116.
22.
Abrams BB: Atopic dermatitis: Elements in clinical study design and analysis. Acta Derm Venereol (Stockh) 1989;suppl 144:15–19.
1999
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.